Documento completo  |  Capítulo completo  |  Expandir índice  |  Versión HTML imprimible
Effective Drug Regulation - A Multicountry Study and Annex 1: Guide for Data Collection to Assess Drug Regulatory Performance
(2002; 187 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoACRONYMS
Ver el documentoPREFACE
Ver el documentoACKNOWLEDGEMENTS
Ver el documentoEXECUTIVE SUMMARY
Abrir esta carpeta y ver su contenido1. DRUG REGULATION: OBJECTIVES AND ISSUES
Abrir esta carpeta y ver su contenido2. MULTICOUNTRY STUDY ON EFFECTIVE DRUG REGULATION
Abrir esta carpeta y ver su contenido3. PROFILE OF THE COUNTRIES
Abrir esta carpeta y ver su contenido4. REGULATORY FRAMEWORK
Abrir esta carpeta y ver su contenido5. REGULATORY CAPACITY
Abrir esta carpeta y ver su contenido6. LICENSING OF MANUFACTURING, DISTRIBUTION AND RETAIL SALE
Abrir esta carpeta y ver su contenido7. INSPECTION AND SURVEILLANCE
Abrir esta carpeta y ver su contenido8. PRODUCT ASSESSMENT AND REGISTRATION
Abrir esta carpeta y ver su contenido9. CONTROL OF DRUG PROMOTION AND ADVERTISING
Abrir esta carpeta y ver su contenido10. DRUG QUALITY CONTROL LABORATORY
Abrir esta carpeta y ver su contenido11. ASSESSING REGULATORY PERFORMANCE
Abrir esta carpeta y ver su contenido12. CONCLUSIONS AND RECOMMENDATIONS FOR EFFECTIVE DRUG REGULATION
Abrir esta carpeta y ver su contenidoANNEX 1: GUIDE FOR DATA COLLECTION TO ASSESS DRUG REGULATORY PERFORMANCE
 

Effective Drug Regulation - A Multicountry Study and Annex 1: Guide for Data Collection to Assess Drug Regulatory Performance

by

Ms Sauwakon Ratanawijitrasin

Mr Eshetu Wondemagegnehu

World Health Organization
2002

WHO Library Cataloguing-in-Publication Data

Ratanawijitrasin, Sauwakon

Effective drug regulation: A multicountry study/by Sauwakon Ratanawijitrasin [and]
Eshetu Wondemagegnehu.

1. Legislation, Drug 2. Drug and narcotic control 3. Comparative study

I. Wondemagegnehu, Eshetu

ISBN 92 4 156206 4
(NLM Classification: QV 33)

The World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. Applications and enquiries should be addressed to the Office of Publications, World Health Organization, Geneva, Switzerland, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available.

© World Health Organization 2002

Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights reserved.

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

Printed in Malta

 

Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019